TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
FHTX

Foghorn Therapeutics Inc

Healthcare · Biotechnology

3.50$ -2.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement FHTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – 13,422.1% 569.7% 0.1% 321.2% 13.8% 10.8%
– – -13,322.1% 100.0% 99.9% 100.0% 100.0% 89.2%
– – 13,422.1% 6,089.8% 549.3% 321.2% 418.2% 276.5%
– – 2,615.3% 1,647.3% 159.9% 94.8% 125.5% 89.1%
– – 2,615.3% 7,737.1% 709.2% 415.9% 554.3% 354.9%
– – -15,937.4% -7,637.1% -609.2% -315.9% -454.3% -265.6%
– – 227.7% 144.5% 60.2% – – –
– – -16,000.0% -7,681.6% -566.3% -275.8% -383.2% -240.3%
– – 227.7% 144.5% 0.0% 12.4% – –
– – -16,000.0% -7,681.6% -566.2% -288.2% -383.2% -240.3%
– – -15,628.8% -7,292.4% -591.9% -265.7% -429.9% -229.5%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?